Valuation: ResMed, Inc.

Market Cap 2.86TCr 2.5TCr 2.32TCr 2.12TCr 4.02TCr 2,76000Cr 4.09TCr 28TCr 11TCr 1,34800Cr 11TCr 11TCr 4,65300Cr P/E 2026 *
18.8x
P/E 2027 * 16.7x
Enterprise Value 2.78TCr 2.43TCr 2.25TCr 2.06TCr 3.91TCr 2,68200Cr 3.98TCr 27TCr 11TCr 1,31000Cr 10TCr 10TCr 4,52200Cr EV / Sales 2026 *
4.93x
EV / Sales 2027 * 4.47x
Free-Float
75.61%
Yield 2026 *
1.23%
Yield 2027 * 1.32%
1 day+1.41%
1 week-3.42%
Current month+3.30%
1 month+3.81%
3 months-10.41%
6 months-21.84%
Current year-16.42%
1 week 190.25
Extreme 190.25
209.36
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%-3.42%-20.82%-8.81% 2.86TCr
+0.55%+2.37%+29.02%+2.26% 20TCr
+1.02%+3.45%+4.88%-14.73% 14TCr
+2.36%-3.35%-22.41%+12.41% 14TCr
+3.85%-0.69%-56.70%-15.07% 6.4TCr
-0.01%-4.75%+14.25%-6.11% 5.03TCr
+1.18%+2.27%-23.75%-31.73% 4.43TCr
-0.23%+0.48%+18.34%+13.51% 3.8TCr
+0.39%-0.13%+30.07%+39.58% 3.68TCr
+1.99%-0.28%-14.49%-20.53% 2.87TCr
Average +1.21%-1.66%-4.16%-2.92% 7.7TCr
Weighted average by Cap. +1.25%-0.27%+0.27%-1.93%

Financials

2026 *2027 *
Net sales 565.02Cr 493.88Cr 456.74Cr 419.12Cr 793.23Cr 54TCr 807.01Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 610Cr 533.2Cr 493.1Cr 452.48Cr 856.38Cr 59TCr 871.26Cr 5.88TCr 2.31TCr 29TCr 2.29TCr 2.24TCr 99TCr
Net income 154.8Cr 135.31Cr 125.13Cr 114.82Cr 217.32Cr 15TCr 221.1Cr 1.49TCr 586.23Cr 7.28TCr 581.32Cr 568.55Cr 25TCr 170.74Cr 149.24Cr 138.02Cr 126.65Cr 239.7Cr 16TCr 243.87Cr 1.65TCr 646.61Cr 8.03TCr 641.2Cr 627.11Cr 28TCr
Net Debt -80Cr -70Cr -65Cr -60Cr -112.85Cr -7.75TCr -114.81Cr -774.95Cr -304.43Cr -3.78TCr -301.88Cr -295.25Cr -13TCr -139.65Cr -122.07Cr -112.89Cr -103.59Cr -196.05Cr -13TCr -199.46Cr -1.35TCr -528.86Cr -6.57TCr -524.43Cr -512.91Cr -23TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
16/26/16 $201.32 +1.38% 4,50,952
15/26/15 $198.57 +2.88% 12,08,785
14/26/14 $193.01 -2.77% 16,22,359
13/26/13 $198.50 -2.63% 21,61,420
10/26/10 $203.87 -2.20% 13,31,149
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
198.57USD
Average target price
252.20USD
Spread / Average Target
+27.01%

Quarterly revenue - Rate of surprise